Cannabis Nanoparticle Application
Cannabis Global, Inc., a licensed Los Angeles-based manufacturer and distributor within the cannabis sector, today provides an update concerning the Company’s patent applications, especially referring to its application to protect inventions and processes for unique cannabis nanoparticles.
Cannabis Global continues to pursue two non-provisional patent applications for cannabis technologies. The primary of these relates to using state-of-the-art production devices to supply nanoparticles and nanofibers made from cannabinoids.
These tiny “pieces” of cannabinoids are only between one hundred and 700 nanometers wide, which is as small as but 1% of the width of a person’s hair.
Cannabis Global plans to use this technology to provide more efficient dosing of cannabinoids during a variety of new products, such as pharmaceuticals, food, beverages, and topical skin preparations.
The non-provisional filing occurred on July 8, 2021, and is currently being reviewed by the U.S Patent and Trademark Office Database.
Additionally, earlier this month, the Company skilled clarifications posed by the U.S. Patent and Trademark Office Database relative to the priority the corporate wished to be given to the several separate inventions within the appliance.
Also read – How Cannabis Testing Labs Help Put Undue Focus on THC Potency.
In addition, Cannabis Global has filed for cover for inventions relating to the creation of cannabosides, which are modifications of the naturally occurring, plant-based cannabinoids that would potentially significantly increase the bio-absorption of cannabis-related compounds by the physical body.
In the case of the Company’s technology to create cannabosides, non-THC containing hemp or THC containing cannabis are fed to insects, which convert the cannabinoids within the feedstock into cannabosides.
The corporate filed the non-provisional patent on January 18, 2021. Cannabis Global has also filed for international protection for both inventions from the International Patent Cooperation Union (PCT).
The PCT assists applicants in seeking patent protection internationally for their inventions, help patent offices with their patent granting decisions and facilitates public access to a wealth of technical information relating to those inventions.
By filing one international application under the PCT, applicants can simultaneously seek protection for an invention in numerous countries via one application.
About Cannabis Global, Inc.
Cannabis Global, Inc. may be a Los Angeles-based, fully audited, and reporting Company with the U.S. Securities & Exchange Commission, trading under the stock symbol CBGL.
We are an emerging force within the cannabis marketplace with a growing product and proprietary property portfolio.
Also read – Cannabis Confidential: David Ortiz Gets In The Marijuana Game
We are marketing and producing Comply Bag™, innovative cannabis storage, transport, and tracking solution.
Our subsidiary, Natural Plant Extract (NPE), is a Southern California licensed cannabis manufacturer and distributor which licenses our technologies to supply edibles for the cannabis marketplace.
Cannabis Global has filed three non-provisional and multiple provisional patents for cannabis infusion and nanoparticle technologies and continues an active research & development program.
This news release contains “forward-looking statements,” which aren’t purely historical and should include any statements regarding beliefs, plans, expectations, or intentions regarding the longer term.
Such forward-looking statements include, among other things, the event, costs, and results of
new business opportunities could also be deemed “forward-looking statements” within the Private Securities Litigation Reform Act of 1995.
Actual results could differ from those projected in any forward-looking statements thanks to numerous factors.
Also read – As More Drivers In Fatal Crashes Use Cannabis, New Report Offers States A Safety Playbook.
Such factors include, among others, the inherent uncertainties related to new projects, the longer-term U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products.
These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the explanations of why actual results could differ from those projected within the forward-looking statements.
Although we believe that any beliefs, plans, expectations, and intentions contained during this press release are reasonable, there is often no assurance that any such beliefs, plans, expectations, or intentions will be accurate.
Investors should consult all of the knowledge set forth herein and ask for the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q, and other periodic reports filed from time to time with the Securities and Exchange Commission.